Novavax Inc (NVAX)
14.40
+1.50
(+11.63%)
USD |
NASDAQ |
May 16, 16:00
14.26
-0.14
(-0.97%)
After-Hours: 07:16
Novavax Market Cap: 2.121B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.121B |
| May 15, 2024 | 1.900B |
| May 14, 2024 | 1.986B |
| May 13, 2024 | 1.931B |
| May 10, 2024 | 1.308B |
| May 09, 2024 | 627.67M |
| May 08, 2024 | 627.67M |
| May 07, 2024 | 647.26M |
| May 06, 2024 | 668.32M |
| May 03, 2024 | 692.19M |
| May 02, 2024 | 661.30M |
| May 01, 2024 | 655.68M |
| April 30, 2024 | 607.95M |
| April 29, 2024 | 602.33M |
| April 26, 2024 | 574.25M |
| April 25, 2024 | 554.59M |
| April 24, 2024 | 582.67M |
| April 23, 2024 | 588.29M |
| April 22, 2024 | 571.44M |
| April 19, 2024 | 557.28M |
| April 18, 2024 | 546.05M |
| April 17, 2024 | 546.05M |
| April 16, 2024 | 560.09M |
| April 15, 2024 | 578.34M |
| April 12, 2024 | 600.80M |
| Date | Value |
|---|---|
| April 11, 2024 | 603.61M |
| April 10, 2024 | 597.99M |
| April 09, 2024 | 620.45M |
| April 08, 2024 | 621.85M |
| April 05, 2024 | 620.45M |
| April 04, 2024 | 623.26M |
| April 03, 2024 | 637.29M |
| April 02, 2024 | 635.89M |
| April 01, 2024 | 652.74M |
| March 28, 2024 | 668.98M |
| March 27, 2024 | 678.77M |
| March 26, 2024 | 659.18M |
| March 25, 2024 | 673.17M |
| March 22, 2024 | 657.78M |
| March 21, 2024 | 660.58M |
| March 20, 2024 | 675.97M |
| March 19, 2024 | 691.37M |
| March 18, 2024 | 719.36M |
| March 15, 2024 | 740.35M |
| March 14, 2024 | 696.97M |
| March 13, 2024 | 734.75M |
| March 12, 2024 | 708.16M |
| March 11, 2024 | 717.96M |
| March 08, 2024 | 762.74M |
| March 07, 2024 | 785.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
96.17M
Minimum
Aug 12 2019
22.99B
Maximum
Feb 08 2021
4.717B
Average
1.489B
Median
Oct 11 2022
Market Cap Benchmarks
| Pfizer Inc | 163.88B |
| Moderna Inc | 50.85B |
| Sensus Healthcare Inc | 105.24M |
| Agilent Technologies Inc | 45.22B |
| BioCryst Pharmaceuticals Inc | 1.335B |
Market Cap Related Metrics
| PS Ratio | 2.138 |
| Price | 14.40 |
| Earnings Yield | -22.22% |